Table of Contents Author Guidelines Submit a Manuscript
Journal of Analytical Methods in Chemistry
Volume 2018, Article ID 6148515, 7 pages
https://doi.org/10.1155/2018/6148515
Research Article

Comparison of Three Sample Preparation Procedures for the Quantification of L-Arginine, Asymmetric Dimethylarginine, and Symmetric Dimethylarginine in Human Plasma Using HPLC-FLD

Experimental Pharmacology and Toxicology Laboratory, Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Ridebanevej 9, 1870 Frederiksberg C, Denmark

Correspondence should be addressed to Jens Lykkesfeldt; kd.uk.dnus@lpoj

Received 29 August 2017; Accepted 26 November 2017; Published 1 February 2018

Academic Editor: Hana Sklenarova

Copyright © 2018 Anne Marie Voigt Schou-Pedersen and Jens Lykkesfeldt. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Tsikas, “Determination of asymmetric dimethylarginine in biological fluids: a paradigm for a successful analytical story,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 11, no. 5, pp. 592–600, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Vallance, A. Leone, A. Calver, J. Collier, and S. Moncada, “Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure,” The Lancet, vol. 339, no. 8793, pp. 572–575, 1992. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Bergstrom, J. M. Staalso, B. Romner, and N. V. Olsen, “Impaired endothelial function after aneurysmal subarachnoid haemorrhage correlates with arginine:asymmetric dimethylarginine ratio,” British Journal of Anaesthesia, vol. 112, no. 2, pp. 311–318, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. J. T. Kielstein, R. H. Böger, S. M. Bode-Böger et al., “Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease,” Journal of American Society of Nephrology, vol. 13, no. 1, pp. 170–176, 2002. View at Google Scholar
  5. V.-P. Valkonen, H. Päivä, J. T. Salonen et al., “Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine,” The Lancet, vol. 358, no. 9299, pp. 2127-2128, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Fleck, F. Schweitzer, E. Karge, M. Busch, and G. Stein, “Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases,” Clinica Chimica Acta, vol. 336, no. 1-2, pp. 1–12, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Teerlink, “HPLC analysis of ADMA and other methylated l-arginine analogs in biological fluids,” Journal of Chromatography B, vol. 851, no. 1-2, pp. 21–29, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Bylda, R. Thiele, U. Kobold, and D. A. Volmer, “Recent advances in sample preparation techniques to overcome difficulties encountered during quantitative analysis of small molecules from biofluids using LC-MS/MS,” Analyst, vol. 139, no. 10, pp. 2265–2276, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Hyötyläinen, “Critical evaluation of sample pretreatment techniques,” Analytical and Bioanalytical Chemistry, vol. 394, no. 3, pp. 743–758, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Blackwell, D. S. J. O’Reilly, and D. K. Talwar, “HPLC analysis of asymmetric dimethylarginine (ADMA) and related arginine metabolites in human plasma using a novel non-endogenous internal standard,” Clinica Chimica Acta, vol. 401, no. 1-2, pp. 14–19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Heresztyn, M. I. Worthley, and J. D. Horowitz, “Determination of l-arginine and NG,NG- and NG,NG-dimethyl-l-arginine in plasma by liquid chromatography as AccQ-Fluor™ fluorescent derivatives,” Journal of Chromatography B, vol. 805, no. 2, pp. 325–329, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Hui, M. Wong, J. Kim, J. Love, D. M. Ansley, and D. D. Y. Chen, “A new derivatization method coupled with LC-MS/MS to enable baseline separation and quantification of dimethylarginines in human plasma from patients to receive on-pump CABG surgery,” Electrophoresis, vol. 33, no. 12, pp. 1911–1920, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Teerlink, R. J. Nijveldt, S. de Jong, and P. A. M. van Leeuwen, “Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography,” Analytical Biochemistry, vol. 303, no. 2, pp. 131–137, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. B.-M. Chen, L.-W. Xia, S.-X. Liang et al., “Simultaneous determination of l-arginine and dimethylarginines in human urine by high-performance liquid chromatography,” Analytica Chimica Acta, vol. 444, no. 2, pp. 223–227, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. W.-z. Zhang and D. M. Kaye, “Simultaneous determination of arginine and seven metabolites in plasma by reversed-phase liquid chromatography with a time-controlled ortho-phthaldialdehyde precolumn derivatization,” Analytical Biochemistry, vol. 326, no. 1, pp. 87–92, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Zinellu, S. Sotgia, L. Deiana, and C. Carru, “Quantification of arginine and dimethylated arginines in human plasma by field-amplified sample injection capillary electrophoresis UV detection,” in Capillary Electrophoresis of Biomolecules, N. Volpi and F. Maccari, Eds., pp. 131–138, Humana Press, New York, NY, USA, 2013. View at Google Scholar
  17. S. M. Bode-Böger, R. H. Böger, S. Kienke, W. Junker, and J. C. Frölich, “Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic no production by dietary-arginine in hypercholesterolemic rabbits,” Biochemical and Biophysical Research Communications, vol. 219, no. 2, pp. 598–603, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Wu and C. J. Meininger, “Analysis of citrulline, arginine, and methylarginines using high-performance liquid chromatography,” Methods in Enzymology, vol. 440, pp. 177–189, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Anderstam, K. Katzarski, and J. Bergström, “Serum levels of NG, NG-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients,” Journal of American Society of Nephrology, vol. 8, no. 9, pp. 1437–1442, 1997. View at Google Scholar
  20. E. Caussé, N. Siri, J. F. Arnal et al., “Determination of asymmetrical dimethylarginine by capillary electrophoresis–laser-induced fluorescence,” Journal of Chromatography B: Biomedical Sciences and Applications, vol. 741, no. 1, pp. 77–83, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Zinellu, S. Sotgia, E. Zinellu et al., “High-throughput CZE-UV determination of arginine and dimethylated arginines in human plasma,” Electrophoresis, vol. 28, no. 12, pp. 1942–1948, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Martens-Lobenhoffer and S. M. Bode-Böger, “Simultaneous detection of arginine, asymmetric dimethylarginine, symmetric dimethylarginine and citrulline in human plasma and urine applying liquid chromatography–mass spectrometry with very straightforward sample preparation,” Journal of Chromatography B, vol. 798, no. 2, pp. 231–239, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. E. Schwedhelm, J. Tan-Andresen, R. Maas, U. Riederer, F. Schulze, and R.H. Böger, “Liquid chromatography–tandem mass spectrometry method for the analysis of asymmetric dimethylarginine in human plasma,” Clinical Chemistry, vol. 51, no. 7, pp. 1268–1271, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. FDA, “Food and drug administration guidance for industry,” Bioanalytical Method Validation, U S Department of Health and Human Services, 2013, https://www.fda.gov/downloads/drugs/guidances/ucm368107.pdf. View at Google Scholar
  25. S. de Jong and T. Teerlink, “Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column,” Analytical Biochemistry, vol. 353, no. 2, pp. 287–289, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. J. D. Horowitz and T. Heresztyn, “An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: methodological considerations,” Journal of Chromatography B, vol. 851, no. 1-2, pp. 42–50, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Luneburg, V. Xanthakis, E. Schwedhelm et al., “Reference intervals for plasma L-arginine and the L-arginine:asymmetric dimethylarginine ratio in the Framingham Offspring Cohort,” Journal of Nutrition, vol. 141, no. 12, pp. 2186–2190, 2011. View at Publisher · View at Google Scholar · View at Scopus